X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-01-29 | TRML | McDade Mark | Dir | P - Purchase | $32.50 | +100,000 | 742,209 | +16% | +$3,250,000 | ||||||
2023-11-17 | TRML | Kulkarni Sandeep Chidambar | CEO | P - Purchase | $16.99 | +4,000 | 729,735 | +1% | +$67,960 | ||||||
2023-11-17 | TRML | Thiara Parvinder | Dir | P - Purchase | $17.31 | +1,000 | 83,782 | +1% | +$17,310 | ||||||
| M | 2023-10-25 | TRML | Castelein Caley | Dir | P - Purchase | $14.03 | +20,000 | 974,558 | +2% | +$280,584 | |||||
| M | 2023-10-24 | TRML | Kulkarni Sandeep Chidambar | CEO | P - Purchase | $11.49 | +9,650 | 725,735 | +1% | +$110,912 | |||||
2023-10-24 | TRML | Kantoff Aaron | Dir | P - Purchase | $11.86 | +7,500 | 45,391 | +20% | +$88,950 | ||||||
| M | 2023-10-24 | TRML | Thiara Parvinder | Dir | P - Purchase | $11.08 | +7,000 | 82,782 | +9% | +$77,540 | |||||
| DM | 2023-06-12 | TALS | Ildstad Suzanne | Dir | S - Sale+OE | $2.55 | -44,020 | 5,079,802 | -1% | -$112,307 | |||||
| M | 2023-06-07 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.43 | -141,062 | 5,123,822 | -3% | -$342,504 | |||||
| M | 2023-06-05 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.53 | -33,390 | 5,264,884 | -1% | -$84,350 | |||||
| M | 2023-06-01 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.53 | -31,531 | 5,298,274 | -1% | -$79,793 | |||||
2023-04-21 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.35 | -15,004 | 5,329,805 | 0% | -$35,231 | ||||||
| M | 2023-04-19 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.27 | -68,743 | 5,344,809 | -1% | -$156,369 | |||||
| M | 2023-04-17 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.14 | -148,982 | 5,413,552 | -3% | -$319,334 | |||||
| A | 2023-03-17 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.06 | -10,436 | 5,562,534 | 0% | -$21,543 | |||||
| A | 2023-03-03 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.06 | -6,806 | 5,572,970 | 0% | -$13,992 | |||||
| A | 2023-03-01 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.05 | -29 | 5,579,776 | 0% | -$59 | |||||
| A | 2023-02-21 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.05 | -3,500 | 5,579,805 | 0% | -$7,185 | |||||
| AM | 2023-02-16 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.05 | -6,551 | 5,583,305 | 0% | -$13,446 | |||||
2023-03-17 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.06 | -10,436 | 5,562,534 | 0% | -$21,543 | ||||||
2023-03-03 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.06 | -6,806 | 5,572,970 | 0% | -$13,992 | ||||||
2023-03-01 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.05 | -29 | 5,579,776 | 0% | -$59 | ||||||
2023-02-21 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.05 | -3,500 | 5,579,805 | 0% | -$7,185 | ||||||
| M | 2023-02-16 | TALS | Ildstad Suzanne | Dir | S - Sale | $2.05 | -6,551 | 5,583,305 | 0% | -$13,446 | |||||
| AM | 2022-07-19 | TALS | Nader Francois | Dir | P - Purchase | $3.61 | +138,500 | 534,187 | +35% | +$500,020 | |||||
2022-08-22 | TALS | Ildstad Suzanne | Chief Scientific Officer | S - Sale | $2.80 | -525,000 | 5,589,856 | -9% | -$1,470,000 | ||||||
2022-07-29 | TALS | Requadt Scott | CEO | P - Purchase | $4.25 | +39,382 | 958,446 | +4% | +$167,374 | ||||||
| M | 2022-07-26 | TALS | Requadt Scott | CEO | P - Purchase | $4.24 | +8,618 | 919,064 | +1% | +$36,571 | |||||
2022-07-22 | TALS | Requadt Scott | CEO | P - Purchase | $3.75 | +9,444 | 910,446 | +1% | +$35,412 | ||||||
| M | 2022-07-19 | TALS | Nader Francois | Dir | P - Purchase | $3.61 | +138,500 | 474,667 | +41% | +$500,020 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |